DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB18493
| null |
Cerium dioxide
|
1306-38-3
|
619G5K328Y
|
Ceric oxide | Cerium oxide | Cerium(iv) oxide
|
OFJATJUUUCAKMK-UHFFFAOYSA-N
|
DB18494
| null |
GTB-3550
| null |
E5GE91Q5FX
|
single chain recombinant trispecific killer engager consistent of anti-CD16 scFV spliced to anti-CD33 scFV with a modified IL-15 linker
| null |
DB18495
| null |
KN-001
| null | null | null | null |
DB18496
| null |
BCX10013
| null | null | null | null |
DB18497
| null |
APR-2020
| null | null | null | null |
DB18498
| null |
BBP-671
| null | null | null | null |
DB18499
| null |
STP-707
| null | null | null | null |
DB18500
| null |
TRK-250
| null | null | null | null |
DB18501
| null |
ISP-001
| null | null | null | null |
DB18502
| null |
AZ-3102
| null | null | null | null |
DB18503
| null |
RAG-17
| null | null | null | null |
DB18504
| null |
ACTX-401
| null | null | null | null |
DB18505
| null |
CEB-01
| null | null | null | null |
DB18506
| null |
EA-2353
| null | null | null | null |
DB18507
| null |
Alflorex
| null | null | null | null |
DB18508
| null |
Sodium arsenite
|
7784-46-5
|
48OVY2OC72
|
Arsenenous acid, sodium salt (1:1) | Arsenious acid, monosodium salt | Arsenious acid, sodium salt | Sodium (meta)arsenite | Sodium arsenenite | Sodium dioxoarsenate | Sodium meta arsenite | Sodium meta-arsenite | Sodium metaarsenite
|
PTLRDCMBXHILCL-UHFFFAOYSA-M
|
DB18509
| null |
Arsenite ion
|
15502-74-6
|
N5509X556J
|
Arsenite | Arsenite anion | Ortho-arsenite
|
OWTFKEBRIAXSMO-UHFFFAOYSA-N
|
DB18510
| null |
KUS-121 free acid
|
1357245-09-0
|
KWL59W4L66
|
1-Naphthalenesulfonic acid, 4-amino-3-[2-[6-(4-fluoro-2-methylphenyl)-3-pyridinyl]diazenyl]- | 4-Amino-3-[[6-(4-fluoro-2-methylphenyl)pyridin-3-yl]azo]naphthalene-1-sulfonic acid | KUS 121 free acid | KUS121 free acid
|
QOLHSSNEBRFIEQ-CYYJNZCTSA-N
|
DB18511
| null |
AP-001
|
660430-03-5
|
P3FX063KLI
|
(4Z,7Z,10R,11E,13E,15Z,17S,19Z) 10,17-DIHYDROXY-DOCOSA-4,7,11,13,15,19-HEXAENOIC ACID | 4,7,11,13,15,19-DOCOSAHEXAENOIC ACID, 10,17-DIHYDROXY-, (4Z,7Z,10R,11E,13E,15Z,17S,19Z)- | NEUROPROTECTIN D1 | NPD-1 | PROTECTIN D1
|
CRDZYJSQHCXHEG-SFVBTVKNSA-N
|
DB18512
| null |
DiaVacs
| null | null | null | null |
DB18513
| null |
MDR-101
| null | null | null | null |
DB18514
| null |
DSP-5336
|
2412555-70-3
|
VW83Y2JLZ5
|
BENZAMIDE, 5-FLUORO-2-((4-(7-(((1S,3S,4R)-5-METHYLENE-2-AZABICYCLO(2.2.2)OCT-3-YL)CARBONYL)-2,7-DIAZASPIRO(3.5)NON-2-YL)-5-PYRIMIDINYL)OXY)-N,N-BIS(1-METHYLETHYL)-
|
JQHJEDMMWUIYCE-FVVBACEJSA-N
|
DB18515
| null |
Revumenib
|
2169919-21-3
|
LZ0M43NNF2
|
Benzamide, n-ethyl-2-((4-(7-((trans-4-((ethylsulfonyl)amino)cyclohexyl)methyl)-2,7-diazaspiro(3.5)non-2-yl)-5-pyrimidinyl)oxy)-5-fluoro-n-(1-methylethyl)- | Revumenib
|
FRVSRBKUQZKTOW-YOCNBXQISA-N
|
DB18516
| null |
Chromium histidinate
|
18984-90-2
|
1BY3EP7D99
|
Chromium, tris(histidinato)- | Chromium, tris(l-histidinato-n,o)- | Chromium, tris(l-histidinato)-
|
QJOSVOSTKBUREB-BBDGQJMTSA-K
|
DB18517
| null |
Salcaprozic acid
|
183990-46-7
|
X88E147FCU
| null |
NJEKDCUDSORUJA-UHFFFAOYSA-N
|
DB18518
| null |
Crinecerfont
|
752253-39-7
|
MFT24BX55I
| null |
IEAKXXNRGSLYTQ-DEOSSOPVSA-N
|
DB18519
| null |
Autologous killer cell
| null | null |
Autologous blood derived natural killer cells | Autologous killer cell
| null |
DB18520
| null |
HMI-203
| null | null | null | null |
DB18521
| null |
Autologous pancreatic islets
| null | null | null | null |
DB18522
| null |
Interferon alfa-1b
| null |
G7407IV2FS
|
IFN .ALPHA.-1B | IFN-ALPHA 1B | INTERFERON ALPHA 1B | Interferon alpha-1b | INTERFERON-ALFA-1B | RINFERON
| null |
DB18523
| null |
Rhenium (186-Re) obisbemeda
|
644961-22-8
|
O5L8T4LD4L
|
Rhenium (186re) obisbemeda
|
WGNFIJYHYDDFMP-LDYDCSBASA-K
|
DB18524
| null |
Autologous skin culture
| null | null | null | null |
DB18525
| null |
NTLA-2001
| null | null | null | null |
DB18526
| null |
Lusacomfar Alfa
|
2640087-71-2
|
AYN2H2T5GU
| null | null |
DB18527
| null |
JAK4D
|
882400-49-9
|
AVX7AUJ938
|
5-oxo-l-prolyl-l-asparaginyl-l-prolyl-d-tyrosyl-d-tryptophanamide | L-pyroglutamyl-l-asparaginyl-l-prolyl-d-tyrosyl-d-tryptophan amide
|
SZQSOKVXBMULDL-VQHLWIOESA-N
|
DB18528
| null |
Adze-1.17-CD40L
| null | null | null | null |
DB18529
| null |
Methionine sulfoximine, (S)-
|
21752-32-9
|
DE3D2PZ3TT
|
(2s)-2-amino-4-((s(s))-s-methylsulfonimidoyl)butanoic acid | Butanoic acid, 2-amino-4-((s(s))-s-methylsulfonimidoyl)-, (2s)- | L-methionine-(s)-sulfoximine | L-S-(3-Amino-3-carboxypropyl)-S-methylsulfoximine
|
QLMUQBNMEHYOAX-AUIPBDMJSA-N
|
DB18530
| null |
Bifidobacterium spp.
| null |
IO1WP3918D
|
BIFIDOBACTERIA | BIFIDOBACTERIUM | BIFIDOBACTERIUM [VANDF] | Bifidobacterium nos [WHO-DD] | BIFIDOBACTERIUM ORLA-JENSEN, 1924 | BIFIDOBACTERIUM SPP. WHOLE
| null |
DB18531
| null |
RHCC10
| null |
MRS7SR55LQ
|
Recombinant human Clara cell 10 kDa protein | Recombinant human club cell protein
| null |
DB18532
| null |
Lactobacillus brevis
| null |
268IL53Q7O
|
BACILLUS CASEI G WHOLE | BACILLUS G WHOLE | BETABACTERIUM BREVE WHOLE | LACTOBACILLUS BREVIS (ORLA-JENSEN, 1919) BERGEY ET AL., 1934 | lactobacillus brevis CD2 | LACTOBACILLUS BREVIS WHOLE | LACTOBACTERIUM BREVE WHOLE
| null |
DB18533
| null |
Liprotamase lipase
| null |
9VP88M3N3O
|
ALTU-135 LIPASE | LIPASE CROSS-LINKED ENZYME CRYSTAL (BURKHOLDERIA CEPACIA) | LIPASE-CLEC (BURKHOLDERIA CEPACIA)
| null |
DB18534
| null |
MUL001
| null | null | null | null |
DB18535
| null |
LB-P8
| null | null | null | null |
DB18536
| null |
Luminol
|
521-31-3
|
5EXP385Q4F
|
3-aminophthalic hydrazide | 5-amino-2,3-dihydro-1,4-phthalazinedione | O-aminophthaloyl hydrazide | O-aminophthalylhydrazide
|
HWYHZTIRURJOHG-UHFFFAOYSA-N
|
DB18537
| null |
VB-310
|
2699021-76-4
|
SH72P2DRU7
| null |
RZFRCPSGNXCKHX-BHFDYALXSA-N
|
DB18538
| null |
CER-001
| null | null |
Recombinant human apolipoprotein A-I/phospholipid complexes
| null |
DB18539
| null |
VB-309
|
2699021-75-3
|
GMN7ZX2D3A
| null |
XHNYCXIHZPYCRT-VSAHRBKJSA-N
|
DB18540
| null |
VB-311
|
2699021-77-5
|
2D48C7R49E
| null |
HSANCOGPVWLQHU-LCDCYPFKSA-N
|
DB18541
| null |
VB-313
|
2699021-79-7
|
VFD5BFU5ZG
| null |
MFUKFDWBLGEBFH-PBFRVRAZSA-N
|
DB18542
| null |
VB-312
|
2699021-78-6
|
MHF3368LWJ
|
(2S,3R,4S,5S,6R)-2-(((2S,3R,4S,5R,6R)-2-(((2R,3S,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(((6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2
|
UPWACTFHHLAPJQ-CSUYZDOWSA-N
|
DB18543
| null |
Cytochrome C
|
9007-43-6
|
Q5ED5J76AX
|
Cyt c | Cytochrome C
| null |
DB18544
| null |
SNP-ACTH (1-39)
| null | null | null | null |
DB18545
| null |
Tildacerfont
|
1014983-00-6
|
09QCEV5481
|
3-(5-chloro-2-morpholin-4-yl-thiazol-4-yl)-7-(1-ethyl-propyl)-2,5-dimethyl-pyrazolo(1,5-a)pyrimidine | Pyrazolo(1,5-a)pyrimidine, 3-(4-chloro-2-(4-morpholinyl)-5-thiazolyl)-7-(1-ethylpropyl)-2,5-dimethyl- | Pyrazolo(1,5-a)pyrimidine, 3-(4-chloro-2-(4-morpholinyl)-5-thiazolyl)-7-(1-ethylpropyl)-2,5-dimethyl-pyrazolo(1,3-a)pyrimidine
|
CLKXPWDYEYIPFS-UHFFFAOYSA-N
|
DB18546
| null |
DengueCide
| null | null | null | null |
DB18547
| null |
SIG-207
| null | null | null | null |
DB18548
| null |
SIG-205
| null | null | null | null |
DB18549
| null |
ASP-7317
| null | null |
ACT hESC-RPE | hESC-derived RPE | hRPE cell therapy | MA09-hRPE
| null |
DB18550
| null |
TTX-siPDL1
| null | null |
Magnetic nanocarrier-conjugated small interfering RNA against programmed death ligand 1
| null |
DB18551
| null |
GSBR-1290
| null | null | null | null |
DB18552
| null |
QXL138AM
| null | null |
Masked immunocytokine (MIC) comprised of an anti-CD138 immunoglobulin G1 antibody fused to interferon alpha 2a
| null |
DB18553
| null |
OSSM-007
| null | null | null | null |
DB18554
| null |
mRNA-3745
| null | null | null | null |
DB18555
| null |
AMT-101
| null | null |
Recombinant human interleukin-10 fusion protein
| null |
DB18556
| null |
Modified Cholera toxin A subunit
| null | null | null | null |
DB18557
| null |
Modified Cholera toxin B subunit
| null | null | null | null |
DB18558
| null |
UX053
| null | null | null | null |
DB18559
| null |
PVX-410 component XBP1 US184-192(YISPWILAV)
|
1200123-74-5
|
W7QU8GP4UY
|
L-valine, l-tyrosyl-l-isoleucyl-l-seryl-l-prolyl-l-tryptophyl-l-isoleucyl-l-leucyl-l-alanyl- | Xbp1 us184-192(yispwilav) | Yispwilav
| null |
DB18560
| null |
PVX-410 component XBP1 SP367-375 (YLFPQLISV)
|
1200123-78-9
|
7AS3WP8FO8
|
L-valine, l-tyrosyl-l-leucyl-l-phenylalanyl-l-prolyl-l-glutaminyl-l-leucyl-l-isoleucyl-l-seryl- | Xbp1 sp367-375(ylfpqlisv) | Ylfpqlisv
| null |
DB18561
| null |
PVX-410 component CS1 239-247(SLFVLGLFL)
|
1200123-84-7
|
EHT3VE7CI1
| null | null |
DB18562
| null |
PVX-410 component CD138 260-268(GLVGLIFAV)
|
1200123-80-3
|
V1QJC0TIE6
|
Cd138 260-268(glvglifav) | Glvglifav | L-valine, glycyl-l-leucyl-l-valylglycyl-l-leucyl-l-isoleucyl-l-phenylalanyl-l-alanyl-
| null |
DB18563
| null |
Pemtumomab
| null | null |
Murine MAb to polymorphic epithelial mucin, human milk fat globule 1
| null |
DB18564
| null |
YT-001
|
1072301-78-0
|
256XF8BC7R
|
L-Threonine, N-(1-oxotetradecyl)-L-α-glutamyl-L-alanyl-L-valyl-L-seryl-L-leucyl-L-lysyl-L-prolyl- | N-myristoylated -Glu-Ala-Val-Ser-Leu-Lys-Pro-Thr
|
JIZVBWPFTIJRJW-XXNHCHLUSA-N
|
DB18565
| null |
Ergidina
| null | null |
Neutralizing scFv dimer to C5 fused at the C terminal end to the Fc domains of human IgG1 and the cyclic RGD-4C peptide (ACDCRGDCFCG)
| null |
DB18566
| null |
MB-107
| null | null | null | null |
DB18567
| null |
B7-H3-specific chimeric antigen receptor T cells
| null | null |
allogeneic T cells genetically modified to express anti-B7-H3 chimeric antigen receptor (CAR) | Autologous chimeric antigen receptor (CAR) T cells targeting B7-H3 | chimeric antigen receptor (CAR) modified recombinant T cells targeting B7-H3
| null |
DB18568
| null |
CLL1-CD33 compound chimeric antigen receptor T cells
| null | null |
Chimeric Antigen Receptor immunotherapy directed against CLL-1 and CD33 | CLL1-CD33 cCAR
| null |
DB18569
| null |
PA3-17
| null | null |
Chimeric Antigen Receptor T Cells targeting CD7
| null |
DB18570
| null |
ISB 2001
| null | null | null | null |
DB18571
| null |
DCVAC/OvCa
| null | null |
Autologous dendritic cells pulsed with killed ovarian cancer cells and matured by TLR3 ligand ex vivo
| null |
DB18572
| null |
PEP0101
| null | null |
Nanocomplex consisting of a small interfering RNA that targets the human EV11 oncogenic transcription factor and an elastin-like polypeptide drug carrier.
| null |
DB18573
| null |
1,2-Dioleoyl-sn-glycero-3-phospho-L-serine
|
70614-14-1
|
KJ401H4834
|
1,2-dioleoyl-sn-glycero-3-phospho-l-serine | 4,6,10-trioxa-5-phosphaoctacos-19-enoic acid, 2-amino-5-hydroxy-11-oxo-8-(((9z)-1-oxo-9-octadecen-1-yl)oxy)-, 5-oxide, (2s,8r,19z)- | Dioleoyl phosphatidylserine | L-serine, 2,3-bis((1-oxo-9-octadecenyl)oxy)propyl hydrogen phosphate (ester), (r-(z,z))-
|
WTBFLCSPLLEDEM-JIDRGYQWSA-N
|
DB18574
| null |
BEA-17
| null | null | null | null |
DB18575
| null |
SPL84-23-1
| null | null | null | null |
DB18576
| null |
AB-G023
| null | null | null | null |
DB18577
| null |
TRK-001
| null | null |
Natural Regulatory T Cells (T-Regs), Expanded with Interleukin-2, ExpAct Beads (CD3/CD28; Miltenyi), Rapamycin and Transforming Growth Factor-beta
| null |
DB18578
| null |
Brigimadlin
|
2095116-40-6
|
9A934ZAN94
| null |
AMTXDBGKYPDTTA-SJVQGLCSSA-N
|
DB18579
| null |
ETX101
| null | null |
non-replicating recombinant adeno associated viral vector, serotype 9, designed to promote increased transcription of SCN1A gene
| null |
DB18580
| null |
PBFT02
| null | null |
Non-replicating recombinant adeno-associated virus serotype 1 vector delivering human GRN gene encoding the protein progranulin
| null |
DB18581
| null |
PBGM01
| null | null | null | null |
DB18582
| null |
scAAV9.U7.ACCA
| null | null |
non-replicating recombinant adeno-associated virus vector containing 4 antisense sequences designed to target exon 2 in the human DMD gene under the control of U7 small nuclear non-coding RNA
| null |
DB18583
| null |
CTR-107
| null | null | null | null |
DB18584
| null |
CSIC002
| null | null |
NP-CSIC002
| null |
DB18585
| null |
BJ-001
| null | null | null | null |
DB18586
| null |
Recombinant human placental growth factor (PLGF-131)
| null |
NOV5VI05MF
|
RECOMBINANT HUMAN PLACENTAL GROWTH FACTOR
| null |
DB18587
| null |
Zelpultide alfa
|
2245003-06-7
|
96HS6QEW3X
|
HUMAN PULMONARY SURFACTANT-ASSOCIATED PROTEIN D (PSPD, SURFACTANT PROTEIN D, SP-D, COLLECTIN-7, SURFACTANT PROTEIN D), NON-COVALENT QUADRUPLE TRIMER, PRODUCED IN HUMAN MYELOGENOUS LEUKEMIA K562 CELLS, GLYCOFORME ALFA | PULMONARY SURFACTANT-ASSOCIATED PROTEIN D (HUMAN RECOMBINANT GLYCOEXPRESS MYELOMA CELL HOMOTRIMERIC QUADRAPLEX AT-100) | PULMONARY SURFACTANT-ASSOCIATED PROTEIN D, RECOMBINANT HUMAN | RECOMBINANT HUMAN PULMONARY SURFACTANT-ASSOCIATED PROTEIN D | recombinant human surfactant protein D | RECOMBINANT SP-D
| null |
DB18588
| null |
Denatonium
|
47324-98-1
|
4IK22DF4OU
|
Benzenemethanaminium, n-(2-((2,6-dimethylphenyl)amino)-2-oxoethyl)-n,n-diethyl | Benzyldiethyl((2,6-xylylcarbamoyl)methyl)ammonium
|
ZFQMTVNLDNXRNQ-UHFFFAOYSA-O
|
DB18589
| null |
2G7
| null | null |
Anti-TGF-beta 2G7 | Anti-TGF-beta antibody 2G7 | Anti-TGF-beta monoclonal antibody 2G7 | Anti-transforming growth factor-beta monoclonal antibody 2G7 | Recombinant humanized anti-transforming growth factor (TGF) beta 3 antibody
| null |
DB18590
| null |
GYM329
| null | null |
recombinant humanized IgG1-based monoclonal antibody which binds to human latent myostatin in a pH dependent manner
| null |
DB18591
| null |
LMB-100
|
1841500-93-3
|
D6AT024T4P
|
Anti-mesothelin-pseudomonas exotoxin 24 cytolytic fusion protein lmb-100 | ANTI-MSLN-PE24 CFP LMB-100
| null |
DB18592
| null |
Afamitresgene autoleucel
| null |
CUY18BJ7BP
|
ADP-A2M4 | afami-cel | AUTOLOGOUS CD4+ AND CD8+ T CELLS OBTAINED BY LEUKAPHERESIS, TRANSDUCED WITH AN HIV-DERIVED SELF-INACTIVATING (SIN) LENTIVIRAL VECTOR, ENCODING AN ENHANCED-AFFINITY T CELL RECEPTOR (TCR) SPECIFIC FOR THE HUMAN MELANOMA ANTIGEN A4 (MAGE FAMILY MEMBER A4, A | MAGE-A4C1032T
| null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.